Literature DB >> 33819928

Inferring latent heterogeneity using many feature variables supervised by survival outcome.

Beilin Jia1, Donglin Zeng1, Jason J Z Liao2, Guanghan F Liu3, Xianming Tan1, Guoqing Diao4, Joseph G Ibrahim1.   

Abstract

In cancer studies, it is important to understand disease heterogeneity among patients so that precision medicine can particularly target high-risk patients at the right time. Many feature variables such as demographic variables and biomarkers, combined with a patient's survival outcome, can be used to infer such latent heterogeneity. In this work, we propose a mixture model to model each patient's latent survival pattern, where the mixing probabilities for latent groups are modeled through a multinomial distribution. The Bayesian information criterion is used for selecting the number of latent groups. Furthermore, we incorporate variable selection with the adaptive lasso into inference so that only a few feature variables will be selected to characterize the latent heterogeneity. We show that our adaptive lasso estimator has oracle properties when the number of parameters diverges with the sample size. The finite sample performance is evaluated by the simulation study, and the proposed method is illustrated by two datasets.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  adaptive lasso; censoring; latent model; mixture distribution; oracle property

Mesh:

Substances:

Year:  2021        PMID: 33819928      PMCID: PMC8237103          DOI: 10.1002/sim.8972

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.497


  11 in total

1.  Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis.

Authors:  E W Steyerberg; M J Eijkemans; J D Habbema
Journal:  J Clin Epidemiol       Date:  1999-10       Impact factor: 6.437

2.  Simultaneous feature selection and clustering using mixture models.

Authors:  Martin H C Law; Mário A T Figueiredo; Anil K Jain
Journal:  IEEE Trans Pattern Anal Mach Intell       Date:  2004-09       Impact factor: 6.226

3.  Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients.

Authors: 
Journal:  J Clin Oncol       Date:  1996-06       Impact factor: 44.544

Review 4.  Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors.

Authors:  F E Harrell; K L Lee; D B Mark
Journal:  Stat Med       Date:  1996-02-28       Impact factor: 2.373

5.  The lasso method for variable selection in the Cox model.

Authors:  R Tibshirani
Journal:  Stat Med       Date:  1997-02-28       Impact factor: 2.373

6.  A flexible parametric survival model for fitting time to event data in clinical trials.

Authors:  Jason J Z Liao; Guanghan Frank Liu
Journal:  Pharm Stat       Date:  2019-04-29       Impact factor: 1.894

7.  C-mix: A high-dimensional mixture model for censored durations, with applications to genetic data.

Authors:  Simon Bussy; Agathe Guilloux; Stéphane Gaïffas; Anne-Sophie Jannot
Journal:  Stat Methods Med Res       Date:  2018-04-15       Impact factor: 3.021

8.  The use of mixture models for the analysis of survival data with long-term survivors.

Authors:  V T Farewell
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

9.  Ultrahigh dimensional feature selection: beyond the linear model.

Authors:  Jianqing Fan; Richard Samworth; Yichao Wu
Journal:  J Mach Learn Res       Date:  2009       Impact factor: 3.654

10.  Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.

Authors:  M Colleoni; H J Litman; M Castiglione-Gertsch; W Sauerbrei; R D Gelber; M Bonetti; A S Coates; M Schumacher; G Bastert; C-M Rudenstam; C Schmoor; J Lindtner; J Collins; B Thürlimann; S B Holmberg; D Crivellari; C Beyerle; R L A Neumann; A Goldhirsch
Journal:  Br J Cancer       Date:  2002-06-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.